| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Ion_trans_dom | 1.09e-02 | 114 | 26 | 2 | IPR005821 | |
| Domain | Ion_trans | 1.09e-02 | 114 | 26 | 2 | PF00520 | |
| Interaction | LCN6 interactions | 1.85e-06 | 67 | 27 | 4 | int:LCN6 | |
| Interaction | FSTL4 interactions | 1.25e-05 | 34 | 27 | 3 | int:FSTL4 | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 3.35e-06 | 199 | 27 | 5 | 2319_DN | |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.35e-06 | 199 | 27 | 5 | 5535_DN | |
| Drug | Methylatropine nitrate [52-88-0]; Down 200; 11uM; HL60; HT_HG-U133A | 7.54e-05 | 193 | 27 | 4 | 3116_DN | |
| Drug | Oxyphenbutazone [129-20-4]; Down 200; 12.4uM; HL60; HT_HG-U133A | 7.69e-05 | 194 | 27 | 4 | 6160_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Down 200; 18uM; HL60; HG-U133A | 7.85e-05 | 195 | 27 | 4 | 1441_DN | |
| Drug | troglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 7.85e-05 | 195 | 27 | 4 | 6191_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; PC3; HT_HG-U133A | 8.00e-05 | 196 | 27 | 4 | 5828_UP | |
| Drug | LY294002; Down 200; 0.1uM; MCF7; HG-U133A | 8.16e-05 | 197 | 27 | 4 | 424_DN | |
| Drug | alpha-estradiol; Down 200; 0.01uM; HL60; HT_HG-U133A | 8.16e-05 | 197 | 27 | 4 | 6169_DN | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; HL60; HT_HG-U133A | 8.16e-05 | 197 | 27 | 4 | 6145_DN | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Up 200; 17.8uM; HL60; HT_HG-U133A | 8.16e-05 | 197 | 27 | 4 | 2351_UP | |
| Drug | MK-886; Down 200; 1uM; MCF7; HG-U133A | 8.16e-05 | 197 | 27 | 4 | 601_DN | |
| Drug | Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; HL60; HT_HG-U133A | 8.32e-05 | 198 | 27 | 4 | 2579_DN | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 8.49e-05 | 199 | 27 | 4 | 7020_UP | |
| Drug | Rauwolscine hydrochloride [6211-32-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 8.49e-05 | 199 | 27 | 4 | 2778_DN | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; HL60; HG-U133A | 8.49e-05 | 199 | 27 | 4 | 1964_UP | |
| Drug | Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; HL60; HT_HG-U133A | 8.65e-05 | 200 | 27 | 4 | 2905_DN | |
| Disease | ovarian carcinoma (is_marker_for) | 2.37e-04 | 28 | 24 | 2 | DOID:4001 (is_marker_for) | |
| Disease | JT interval | 1.04e-03 | 248 | 24 | 3 | EFO_0007885 | |
| Disease | 3-hydroxypropylmercapturic acid measurement | 2.83e-03 | 352 | 24 | 3 | EFO_0007014 | |
| Disease | QT interval | 8.99e-03 | 534 | 24 | 3 | EFO_0004682 | |
| Disease | breast cancer (is_marker_for) | 9.86e-03 | 185 | 24 | 2 | DOID:1612 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FPIHFVYRNARRAFA | 596 | Q8TAP6 | |
| FFHPRYHHREFRFDL | 146 | P18075 | |
| HPFFYRRHITLRLGA | 136 | Q13258 | |
| YHRFLGRHFPRFYVL | 71 | Q6P1Q0 | |
| YFTNRFPRLLLHTHR | 881 | Q76MJ5 | |
| GQHFLHFRYRLPLSH | 151 | Q96DT0 | |
| RRGSHPYIDFRIFHS | 81 | Q13946 | |
| FYFLRSLHRNLLHNP | 71 | Q9H4M3 | |
| RLRYLHHFQVHPFFR | 346 | Q96LW2 | |
| LLRAPFRCYHFIFHS | 16 | Q8IVH4 | |
| RHPGFFLSLLHFYRT | 106 | Q96KK3 | |
| DPRLLFRHYSRAYFP | 106 | Q8IWF2 | |
| FLGYHHVSRRFRTFL | 1511 | O95248 | |
| LFLYRARSAFPYAHR | 81 | Q9HAB8 | |
| PAPRHAFEIFRRFYL | 526 | Q13618 | |
| RFRFRAFHFLNRFPS | 2341 | Q9UGM3 | |
| YSHFQHLLYRRFAPD | 286 | Q969F9 | |
| YLPLFREAFSRRHFQ | 36 | O60811 | |
| NRTVAHHFPRLLYFT | 121 | Q9P2E5 | |
| PFHERFFRFLLRKLY | 676 | P38435 | |
| RRYRPFARSHSFRFH | 1531 | Q9BX84 | |
| HVHRRFLPFEALSRY | 1501 | Q9C0A1 | |
| SHARFYFLFHRPLRL | 406 | Q9NV64 | |
| YLRHVPLRRVHLFTF | 941 | Q9Y6R1 | |
| RLFRFPYYLSRHRLS | 51 | Q8NAF0 | |
| HLTRRDIRHNFSPYF | 261 | Q9H3S5 | |
| RHFPFKALHFYLIRA | 126 | Q96L15 |